$0.2334
Last update: Dec 11, 3:01 PM
Zelira Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
There have been no specific sales or earnings guidance reported for Zelira Therapeutics in recent months.
Browse guidance and forecast on all stocks.